ARCHIVES

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

February 22, 1985

NIH Solicits Grant applications For New Type Of Small Business Award; 40 To Be Funded

September 10, 1993

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992

In Brief: Ashworth Named Center Director at UCSF

March 21, 2014

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent.

February 23, 2001